CYP19A1 and breast carcinoma: Efficient reduction of MMP-2 and -9 levels was observed during in vitro treatment of MCF-7 breast cancer cells with the aromatase-inhibitor letrozole suggesting that this inhibitor suppresses both breast cancer growth and invasion [14].